Perspective from John F. Doane, MD
October 05, 2018
1 min read
Save

FDA approves ReLEx SMILE for myopia with astigmatism

Perspective from John F. Doane, MD
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The FDA has issued premarket approval for ReLEx SMILE to treat myopia with astigmatism, Zeiss announced in a press release.

The procedure, which is performed with the VisuMax femtosecond laser, may be potentially less disruptive to corneal surface tissue due to a small entry incision.

“The expansion of myopia treatment to patients with astigmatism will enable current and future SMILE surgeons to expand their patient base, paving the way for a new generation of refractive surgery patients,” Jim Mazzo, global president ophthalmic devices at Zeiss, said in the release.